Mitiglinide [Glufast] 5mg and 10mg tablets in combination with an α-glucosidase inhibitor have been approved in Japan for glycaemic control

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1590, 2007-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olmesartan medoxomil [Olmetec; Sankyo] and mitiglinide [Glufast; Kissei] have been approved in Japan

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Sitaxentan [Thelin; Encysive Pharmaceuticals] 100mg tablets have been launched in Belgium and Luxembourg

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Tanabe Seiyaku have launched methotrexate [Tanabe] 2mg tablets for rheumatoid arthritis (RA) in Japan.

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Health Canada has approved ethinylestradiol/levonorgestrel 0.03mg/0.15mg tablets [Seasonale; Paladin Labs] for contraception.

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Clinical Utility of Acarbose, an -Glucosidase Inhibitor in Cardiometabolic Disorders

By  

Current Drug Metabolism, Vol. 10, Iss. 2, 2009-02 ,pp. : 159-163

Bentham Science Publishers

Access to resources Recommend Favorite